CTNM
Contineum Therapeutics, Inc.Closed8.42−0.15 −1.69%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 8.33 −1.07%
Open
8.50
Prev close
8.57
Day range
8.108.94
52-week range
8.1017.79
Volume
2.65M4.01×
Mkt cap
316.77M
P/E ttm
—
Fwd P/E
-4.39
EPS ttm
-1.73
Div yield
0.00%
Earnings
Jul 30, 2026
From 52w high
−52.66%
CTNM earnings and estimates
CTNM Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Oct 29
After the close · estimated
EPS consensus
$−0.45
range −0.51 – −0.40
EPS growth vs year ago
−0.6%
year ago −0.45
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±22.6%
by Nov 20 · ATM straddle
Past 4 reactions
±2.6%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Jul 30, 2026 AMC | −0.40 | −0.45 | +10.83% | $0 | −1.7% | −2.5% |
| Mar '26 | May 5, 2026 AMC | −0.39 | −0.53 | +26.61% | $0 | +3.8% | −5.1% |
| Dec '25 | Mar 5, 2026 AMC | −0.49 | −0.39 | −26.10% | $0 | +0.5% | +0.4% |
| Sep '25 | Oct 30, 2025 AMC | −0.45 | −0.46 | +1.56% | $0 | +4.5% | +4.5% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.45 | −0.51−0.40 | −0.6% | $0 | 0.0% | −0.45 +0.3% | −0.43 −5.7% | 3 / 3 |
| Next quarter Dec 2026 | −0.45 | −0.55−0.33 | +7.9% | $0 | 0.0% | −0.31 −47.7% | −0.37 −20.6% | 0 / 1 |
| Current year Dec 2026 | −1.70 | −1.85−1.52 | +21.9% | $0 | 0.0% | −1.56 −9.0% | −1.65 −2.9% | 1 / 1 |
| Next year Dec 2027 | −1.92 | −2.55−1.43 | −13.1% | $0 | 0.0% | −1.80 −6.7% | −1.81 −5.7% | 1 / 2 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.45 | −0.51−0.40 | 3 | 0 / 0 |
| Dec 2026 | −0.43 | −0.47−0.39 | 3 | 0 / 0 |
| Mar 2027 | −0.40 | −0.40−0.39 | 2 | 1 / 0 |
| Jun 2027 | −0.40 | −0.40−0.39 | 2 | 1 / 0 |
| Sep 2027 | −0.37 | −0.41−0.32 | 2 | 1 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −1.68 | −1.73−1.58 | 3 | 0 / 0 |
| Dec 2027 | −1.64 | −1.84−1.43 | 3 | 1 / 0 |
| Dec 2028 | −1.50 | −1.64−1.35 | 2 | 1 / 0 |
| Dec 2029 | −1.26 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.